ARS Pharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-31.2M | $-32.1M | $917.0K | $2.6M |
| FY2021 | $-17.6M | $-17.6M | $55.0K | $2.8M |
| FY2022 | $-40.1M | $-40.3M | $199.0K | $5.8M |
| FY2023 | $-59.3M | $-59.4M | $175.0K | $9.2M |
| FY2024 | $13.5M | $13.0M | $563.0K | $14.5M |
| FY2025 | $-170.9M | $-171.2M | $339.0K | $22.1M |